Digitalis Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Omni Pet secures £11m in funding led by IW Capital for veterinary-grade protein nutrition for dogs

22 Jun 2026

Omni Pet secures £11m in funding led by IW Capital for veterinary-grade protein nutrition for dogs

Omni Pet is a science-led pet health company that develops calorie-controlled, novel protein foods, treats and supplements for dogs, replacing common allergens such as beef, chicken and dairy with yeast, algae and pulse-based alternatives. Founded by a practising veterinarian, the brand targets dogs with obesity, food allergies and gut sensitivities, and provides round-the-clock vet access to pet owners.

T-Therapeutics

13 Nov 2025

T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease

T-Therapeutics develops next-generation T cell receptor therapies designed to target cancer and autoimmune disease, advancing bispecific molecules that selectively remove disease-driving immune cells while preserving healthy function.

Digitalis Ventures